Holdings
Almitas Capital LLC
As of Jun 30, 2026, Almitas Capital LLC reported 52 positions worth US$114M. Largest: Amylyx Pharmaceuticals, Inc., Design Therapeutics, Inc. and Cannae Holdings, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. | 975K | US$17.5M | −1.15M | Jun 30, 2026 |
| Design Therapeutics, Inc. | 1.03M | US$14.9M | −503K | Jun 30, 2026 |
| Cannae Holdings, Inc. | 741K | US$10.7M | no change | Jun 30, 2026 |
| Lyell Immunopharma, Inc. | 581K | US$8.17M | +3,600 | Jun 30, 2026 |
| An2 Therapeutics, Inc. | 1.47M | US$7.11M | −10,000 | Jun 30, 2026 |
| Alx Oncology Holdings Inc. | 2.94M | US$6.08M | −235K | Jun 30, 2026 |
| Brightspire Capital, Inc. | 769K | US$4.19M | −247K | Jun 30, 2026 |
| Crescent Capital Bdc, Inc. | 357K | US$3.9M | no change | Jun 30, 2026 |
| Elme Communities | 2.62M | US$3.88M | +11,875 | Jun 30, 2026 |
| Ladder Capital Corp | 340K | US$3.39M | +50,000 | Jun 30, 2026 |